Investor

Presentation

2024 Annual Report

2025 Quarter 1 ReportRainbow Global Global Operation Manufacturing Subsidiary /

Center Base Office R&D Centers

Spain Manufacturing Base Weifang Jinan R&D Centers 7700+ Registrations Globally

Jinan Global Operation Center

U.S. Houston Champaign

Manufacturing Base

Weifang Qingdao Ningxia

Manufacturing Bases

Weifang Process Development Center

4800+ Staffs Globally

110+ Overseas Subsidiaries

100+ Countries Presence Argentina Manufacturing Base

300+ Independent PatentsIndustry Overview Of 2024

During the reporting The exchange rate The inventory levels in

period the industry fluctuation range has overseas markets

remained in a situation increased for some remain at a persistently

where supply exceeded important crop low level and the

demand and competition protection products demand for crop

in the market was still markets and the risk of protection products in

fierce with the prices of debt default has also the global market has

most of the technical- risen which has an returned to normal and

products remaining low adverse impact on the is relatively robust.but stabilizing. stability of business

activities in the local

market.Industry Overview

The trend of the export quantity of formulated products under China's Customs HS Code 3808.

2025202420232022

30.00

28.62

28.0027.4826.93

25.47

26.0025.18

24.8624.4824.92

24.0023.11

22.3324.0622.21

22.0022.9922.54

20.7021.3321.83

19.5719.75

20.00

18.5118.9018.75

18.0017.4317.9918.77

19.25

17.21

16.0015.96

17.10

14.43

14.3914.6715.4114.42

14.00

13.82

12.8313.2112.0011.95

10.0010.50

123456789101112

* The total export quantity under HS code 3808 in 2024 increased by 30.03% year-on-year.* The total export quantity under HS code 3808 in the first quarter of 2025 increased by 12.39% year-on-year.Industry Overview

The trend of the export value of formulated products under China Customs HS Code 3808.

2025202420232022

12.00

11.0711.35

11.05

11.0010.47

10.009.86

9.02

9.00

8.007.697.647.887.447.797.71

7.267.717.28

…7.507.276.667.006.31

7.156.816.586.946.326.756.656.416.58

6.006.075.425.536.12

5.90

5.605.82

5.004.945.41

4.004.59

3.00

2.00

123456789101112

* The total export value under HS code 3808 in 2024 increased by 11.66% year-on-year.* The total export value under HS code 3808 in the first quarter of 2025 increased by 8.47% year-on-year.Industry Overview

The trend of the average export price of formulated products under China Customs HS Code 3808.

2025202420232022

7.00

6.00

6.005.855.975.655.585.355.325.485.31

4.93

5.004.56

4.574.134.173.884.41

4.003.59

3.263.27

2.983.172.873.043.152.793.073.08

3.002.752.872.922.973.033.043.142.922.96

2.86

2.672.69

2.00

1.00

-

123456789101112

* In 2024 the monthly average export unit price under HS code 3808 decreased from USD 2.98 per Kg in

January to USD 2.86 per Kg in December.* In the first quarter of 2025 the monthly average export unit price under HS code 3808 decreased from USD 2.87

per Kg in January to USD 2.69 per Kg in March.2024 Full Year Operational Analysis

To support the achievement of the company's vision and ensure that the company's global

The company has established a global operations can be effectively managed and governed the company has increased its

investment in process and IT construction. In terms of IT the company has specified that it

management system based on nine core will continue to invest until the end of 2029 to achieve a global coverage rate of over 95%

processes aiming to continuously for systems such as SAP CRM BI comprehensive budget system and global collaboration

enhance and improve its global tools. In terms of processes it has been determined that by the end of 2029 the

construction and full implementation of the four major main business processes (DSTE

operational capabilities. MTC CTP PTD) and the five major supporting processes will be completed.* While intensively cultivating the business in existing target markets we have newly

completed in-depth market research in Senegal Sierra Leone Liberia Libya Italy the

United Kingdom Croatia Romania and other markets.Continuously improve the global * We have newly launched the sales of the Rainbow brand in countries such as Mexico

Australia Italy Romania Germany Slovakia Moldova Lithuania Tunisia Algeria Belarus

marketing network. Azerbaijan Bangladesh South Korea Mongolia Botswana Namibia and so on.* A global Rainbow Bio products team has been newly established and the Rainbow Bio

products business has been launched in relevant countries in an orderly manner in

accordance with the plan.* In this year we have newly obtained over 1000 registrations. As of December 31 2024

the company has a total of over global pesticide registration certificates.* We have obtained registrations for the first time in countries such as the United States

Canada Italy Romania France Germany Portugal Ireland Slovakia Moldova Estonia

Lithuania Belarus Tunisia Algeria Trinidad and Tobago and so on.Analysis of the Full - year Operations in 2024

* Increase the proportion of To C business: During the reporting period we made all-out

All four major strategy growth efforts to promote the growth of the To C business. The revenue proportion of the To C

business continued to rise increasing from 33.82% in 2023 to 37.65%. The gross profit

directions specified in the company's margin of the To C business during the reporting period was 28.99% a year-on-year

strategic plan are being advanced increase of 0.09%.smoothly. * Increase the proportion of business in EU and North America: The proportion of business

in EU and North America increased from 5.69% in 2023 to 9.75%.* Increase the proportion of insecticides and fungicides: The revenue proportion of the

insecticide and fungicide business increased from 25.41% in 2023 to 25.71%.* Strengthen the business expansion of Rainbow Bio segment: A global Rainbow Bio team

was established and Rainbow Bio products achieved the sales target of approximately

US$10 million in the first year of revenue.The fluctuation range of exchange rates in some important markets for crop protection

products as well as the risk of debt default have increased. In particular countries such as

The fluctuations in exchange rates in Brazil and Argentina have suffered significant losses related to foreign exchange due to

some markets and the risks of debt substantial exchange rate depreciation losses caused by the risk of debt default and have

been dragged down by the factor of previously high-cost inventory which has affected the

defaults have dragged down the company's overall annual performance.company's overall annual performance.Overall Performance Overview

Financial Data Analysis in 2024 (Year-on-year)

Increase Or

Project In 2024 In 2023 Note

Decrease Rate

With the implementation of strategic

plans in various countries the efforts to

Sales

13296203422.72 11484792643.38 expand the market have been

revenue 15.77% continuously intensified and the

revenues of major regions have steadily

increased.Intensified market competition led to a

year-on-year decline in the gross profit

Gross profit rate 19.79% 21.19% -1.40% margin of Model A/B business resulting

in a decrease in the overall gross profit

margin.Net profit The decline in gross profit margin and

attributable to the the increase in expenses especially the 450082509.47 771120761.85 -41.63% growth of financial expenses and sales

parent company

expenses have led to the decline in net

shareholders profit attributable to the parent company.Net business The improvement of proceeds from

activities generated 751338988.37 -1350375311.36 155.64% sales led to a year-on-year increase in the

cash flow net cash flow from operating activities.Overall Performance Overview

Financial Data Analysis for 2024 (Year-on-year)

Increase Or

Project In 2024 In 2023 Note

Decrease Rate

This is mainly due to the increase in the

salaries of overseas employees

information consultation fees related to

Sales expenses 654095305.31 432967568.95 51.07%

registration advertising expenses

export credit insurance and travel

expenses during the reporting period.It is mainly due to the increase in

Administrative consulting fees amortization of

547396454.50 515227243.83 6.24% intangible assets and compensation of

expense overseas employees during the reporting

period.The experimental expenses related to

registration have been capitalized and

Research and amortized year by year. However in the

same period last year these

development 169415449.97 298481326.30 -43.24% experimental expenses were directly

expenditure expensed resulting in a decline in

research and development expenses

compared with the same period last year.Overall Performance Overview

Financial Data Analysis for 2024 (Year-on-year)

Increase Or

Project In 2024 In 2023 Note

Decrease Rate

Net interest income 83051699.44 19332521.19 329.60%

The year-on-year impact on

profit from finance costs +

gains and losses from foreign

Service charge 41749918.62 22326965.58 86.99% exchange locks was a

decrease in profit mainly due

to a decrease in profit from

losses on foreign exchange

Exchange gains and and foreign exchange locks a

losses (net loss with "+" 552550123.94 -78666068.98 -802.40% decrease in profit from an

fill column) increase in net interest and a

decrease in profit from an

increase in surcharges.Gains and losses arising

from exchange lock (Net -112127909.61 175410040.39 163.92%

loss is represented by "+")Overall Performance Overview

Financial Data Analysis for the First Quarter of 2025 (Year-on-year)

Increase Or

Project Quarter 1 2025 Quarter 1 2024 Note

Decrease Rate

Sales

2686285834.39269319198.95-0.26%

revenue

The gross profit margins of both Model

Gross profit rate 19.27% 20.10% -0.83% A/B and Model C have declined resulting in a decrease in the overall gross profit

margin.Net profit attributable The year-on-year impact on profit from

to the parent company 256742629.50 152843351.25 67.98% finance costs + gains and losses from lock-ups was an increase in profit leading

shareholders to an increase in net attributable profit.Net business

activities generated -66760267.05 -297983503.10 77.60%

cash flowOverall Performance Overview

Financial Data Analysis for the First Quarter of 2025 (Year-on-year)

Increase Or

Project Quarter 1 2025 Quarter 1 2024 Note

Decrease Rate

It was mainly due to the increase in

Sales expenses 160867196.07 136012126.19 18.27% salary and export credit insurance during

the reporting period.Administrative It is mainly due to the increase in

126256414.43 95232946.97 32.58% compensation and depreciation and

expense amortization during the reporting period.Research and

It was mainly due to the increase in

development 41478564.79 36086891.09 14.94% salary during the reporting period.expenditureOverall Performance Overview

Financial Data Analysis in the first quarter of 2025 (year-on-year)

Increase Or

Project Quarter 1 2025 Quarter 1 2024 Note

Decrease Rate

Net interest income 21039185.87 10085118.39 108.62%

The year-on-year impact of

Service fee 10752087.30 7856597.51 36.85% finance costs + gains and

losses from foreign exchange

locks on profit was an increase

in profit mainly due to

Exchange gains and increased profit from foreign

losses (net loss with "+" -190107477.77 55606835.61 441.88% exchange and foreign exchange

fill column) lock gains.Gains and losses arising

from exchange lock (Net 27246355.68 -13729994.95 -298.44%

loss is represented by "+")Overall Performance Overview

Comparison of business model revenue ratio (year-on-year)

Proportion of annual revenue on

Proportion of quarterly revenue on different business models

different business models

Mode C Mode C Mode C Mode C Mode C

Model C

37.65%33.82%38.39%37.43%37.17%

37.73% Model A+Mode A + Moodedl eB A+ Mode A + Mode A + Mode A +

Mode B 6M2o.d2e7 B% Mode B Mode B Mode B

62.35%66.18%61.61%62.57%62.83%

2024 2023 First quarter of 2025 Fourth quarter of 2024 First quarter of 2024Overall Performance Overview

Gross margin ratio comparison on different business models

Quarterly gross margin ratio comparison on

Annual gross margin ratio on different business models

different business models

35.00%35.00%

30.00%28.99%28.90%30.00%29.10%28.17%27.92%

25.00%25.00%

20.00%20.00%

17.24%

14.23%14.77%15.00%15.00%13.72%

12.36%

10.00%10.00%

5.00%5.00%

0.00%0.00%

Mode A + Mode B Mode C Mode A + Mode B Mode C

2024 2023 2025Q1 2024Q4 2024Q1Overall Performance Overview

Comparison of revenue proportion on different categories of products

Proportion of annual revenue on

Proportion of quarterly revenue on different categories of products

different categories of products

Other Other Other Other

Fungicide Fungicide

Other

1.10% 1.25% Fungicide Fungicide11.97% 10.78% 1.19% 1.21%

Fungicide 1.21%

9.88%10.52%10.52%

Insecticide Insecticide Insecticide Insecticide Insecticide

15.83%13.44%16.50%15.90%13.99%

Herbicide Herbicide

Herbicide Herbicide

Herbicide

73.34%71.53%73.19%72.36%

74.28%

In 2024 In 2023 First quarter of 2025 Fourth quarter of 2024 First quarter of 2024Overall Performance Overview

Comparison of gross margin ratio on different categories of products

Comparison of annual gross margin ratio on Comparison of quarterly gross margin ratio on

different categories of products different categories of products

35.00%30.00%

32.88%

26.91%26.87%26.56%

30.00%

25.00%

26.91%

22.00%

21.10%

25.00%20.09%

22.05%22.19%20.00%

18.08%

17.26%

20.00%18.46%15.80%

17.76%

15.00%

15.00%

10.00%

10.00%

5.00%5.00%

0.00%0.00%

2024 2023 2025Q1 2024Q4 2024Q1Global Crop Protection Products Market Outlook in 2025

Most crop protection active

Adjustments in Procurement

The crop protection industry ingredient prices are expected

Behavior Among Distributors &

remains at the cyclical bottom. to remain range-bound at

End-Users.cyclical lows.China and Indian production capacities remain The prices of most active ingredients have already Distributors and end-users are increasingly adopting

severely oversupplied. By 2025 the market will hit historical lows—many even breaking through lean inventory practices—delaying purchases buying

transition from a "destocking" phase to a "capacity previous bottom levels—reaching a point where on-demand and fragmenting orders—with a clear

rationalization" stage intensifying competition to further declines seem unsustainable. However given reluctance to commit to advance procurement plans

unprecedented levels. the massive capacity expansion and subsequent preferring last-minute purchases just before

supply release from China and India over the past application seasons. This shift poses significant

It is anticipated that after a period of painful industry

three years most active ingredients will remain in a challenges for crop protection companies in supply

consolidation and capacity optimization less

state of oversupply prolonging their bottom- chain orchestration.competitive players will gradually exit the market.bouncing phase.This will further increase industry concentration

creating expanded growth opportunities for leading

companies with competitive advantages.The eventual winners will be those who control

technology cost efficiency and market access—

solidifying their position as long-term industry

leaders.Global Crop Protection Products Market Outlook in 2025

Generic crop protection products Market demand is expected to

Occasional incidents may trigger

with cost-performance advantages continue recovering with end-user

significant price fluctuations for

are gaining market share at an prices gradually stabilizing at more

specific products.accelerating pace rational levels.When products hover near historic price floors The sustained decline in active ingredient prices With the depletion of high-cost inventories across

unexpected shocks can trigger abrupt swings— for most crop protection products in recent years most downstream markets the irrational

demanding nimble inventory control and tactical has further accentuated the cost-performance clearance-sale price dumping previously seen

market responses to mitigate exposure. advantages of generic agrochemicals. among competitors has significantly subsided. As

Concurrently as commodity crop prices soften supply-side costs decline gross margins in these

growers—seeking to optimize returns—are markets are steadily recovering bringing

increasingly favoring high-value generic solutions profitability back to rational levels.accelerating their market share growth.Business Outlook of the Company in 2025

The escalation of trade protectionism across various

Market prices and gross profit margins at the retail

countries has led to substantial disruptions in import

1 level are steadily stabilizing to reasonable levels tariffs market access policies exchange rates and 2 with most subsidiaries in key target countries

commodity market prices potentially heightening

projected to sustain margin growth.operational uncertainties for the company.As the TO C segment's revenue contribution expands The development of a process- and IT-driven global

and high-value registrations in major global markets management system is enhancing worldwide

3 are secured the company's overall gross margin will 4 operational efficiency leading to continuous

continue to rise. optimization in operational performance.Aligned with its 2025 objectives the company

5 anticipates steady year-on-year growth in both total

revenue and shareholder net profit.Medium-term Strategic Plan (2025-2029)

The Guiding Principles

"Enhancing quality and efficiency" – prioritizing the improvement of operational quality over the

expansion of revenue scale. We seek progress while maintaining stability and pursue excellence within

that progress. Ensuring health operational safety and controllable risks we aim to grow stronger and

larger steadily advancing on the path toward realizing the company's vision.Medium-term Strategic Plan (2025-2029)

Four major strategy growth directions

1 Increase the proportion of business TO C

2 Increase the proportion of EU and North American business

3 Increase the proportion of insecticides and fungicides

4 Strengthen the business development of biological productsMedium-term Strategic Plan (2025-2029)

Seven Key Tasks

1. Continue to improve and optimize the global management system based on nine core processes to ensure that the global

operation is managed well and with good governance.

2. Through forward-looking portfolio planning we prioritize global registration strategies and commercialization

preparedness for key products to ensure first-to-market authorization and successful launch in strategic markets.

3. Continuous optimization synthesis of existing active ingredients while ensuring high-standard execution for new active

ingredients synthesis thereby enhancing the competitiveness of our self-produced active ingredients and strengthening

their role in market expansion.

4. Continuously enhance formulation development system to facilitate product registration reliable delivery and successful

commercialization.

5. Pursue sustained global business expansion and market penetration reinforced by strategic brand-building initiatives to

ensure balanced and healthy business growth.

6. Gain end-to-end supply chain visibility to enable precise procurement decisions diversify strategic supplier partnerships

and build a secure competitive global supply network.

7. Continuously optimize and efficiently operate the delivery system to ensure high-quality low-cost and fast on-time order

fulfillment.Medium-term Strategic Plan (2025-2029)

Build five core capabilities

1 Global Operation Capability

2 Brand and Channel Development Capability

3 Agile Efficient and Data-Driven Supply Chain Capability

4 The ability to successfully commercialise key products

Cost-Effective and Highly Synergistic Differentiated Formulation

5 Technology Capability

Should there be any difference in the interpretation of the contents the Chinese versions of the

2024 annual report and the 2025 first quarter report shall prevail.To be a Global Leading Crop

Protection Company

Thank You